Table 5.
Changes in Anatomical and Volumetric Functional Metrics Early (1 month) after IAT for the 2 Readers for Non-Targeted Lesions (N = 10)
| Reader 1 |
Reader 2 |
|||||||
|---|---|---|---|---|---|---|---|---|
| Parameter | Before treatment | After treatment | Mean percentage change (%) | P value⁎ | Before treatment | After treatment | Mean percentage change (%) | P value⁎ |
| Anatomical metrics | ||||||||
| RECIST (cm) | 4.2±1.4 | 4.3±1.2 | 2.4±17.2 | 0.7 | 4.1±1.5 | 4.0±1.3 | − 1.3±17.7 | 0.8 |
| mRECIST (cm) | 3.8±1.4 | 3.4±1.5 | − 11.1±9.3 | 0.5 | 3.4±1.3 | 3.1±1.7 | − 7.7±28.0 | 0.5 |
| EASL (cm2) | 12.3±8.4 | 9.9±6.0 | − 19.7±28.3 | 0.4 | 9.0±6.6 | 8.9±6.9 | − 0.8±4.7 | 0.97 |
| Volumetric metrics | ||||||||
| Hepatic arterial (%) | 39.2±32.2 | 54.0±41.0 | 37.9±27.3 | 0.09 | 38.7±31.5 | 55.1±42.0 | 42.1±33.2 | 0.07 |
| Portal venous (%) | 51.2±31.0 | 84.3±54.1 | 64.7±74.7 | 0.05 | 51.6±32.1 | 84.9±55.4 | 64.6±73 | 0.05 |
| ADC (× 10− 3 mm2/s)⁎ | 1.308±0.535 | 1.475±0.227 | 12.7±57.5 | 0.4 | 1.266±0.509 | 1.425±0.243 | 12.6±52.1 | 0.5 |
Note. Unless otherwise indicated, data are means ± standard deviations. *P value is obtained from independent-samples t test.
⁎
ADC map was not available in 4 non-targeted lesions.